promotes tumor growth and cell proliferation by accelerating the G1-S phase transition via AKT/FOXO3a signaling activation, p21Cip1/ p27Kip1 downregulation, cyclin D1 upregulation, and PHLPP1 and PHLPP2 repression. Here, CDKN1B is linked to neoplasm.